Australia markets closed

Regulus Therapeutics Inc (7RG0.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
1.6200-0.0400 (-2.41%)
As of 08:07AM CEST. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-31,367
-30,037
-28,323
-27,808
-15,730
-
Depreciation & amortisation
260
227
122
459
467
-
Stock-based compensation
3,376
2,801
2,177
2,923
2,614
-
Change in working capital
164
257
550
914
-41
-
Accounts payable
-175
29
-110
-250
-786
-
Other working capital
-28,237
-27,381
-25,887
-24,379
-12,547
-
Other non-cash items
142
141
133
46
154
-
Net cash provided by operating activities
-27,396
-26,768
-25,526
-24,128
-12,536
-
Cash flows from investing activities
Investments in property, plant and equipment
-841
-613
-361
-251
-11
-
Purchases of investments
-83,214
-4,899
-32,759
0
-
0
Sales/maturities of investments
5,000
20,000
18,000
0
-
0
Net cash used for investing activities
-79,052
14,491
-15,120
-251
-11
-
Cash flows from financing activities
Debt repayment
-3,304
-3,304
0
-80
-10,277
-
Common stock issued
109,028
15,120
4,491
53,791
19,123
-
Net cash used provided by (used for) financing activities
105,726
11,816
4,491
53,737
9,513
-
Net change in cash
-722
-461
-36,155
29,358
-3,034
-
Cash at beginning of period
30,370
24,290
60,445
31,087
34,121
-
Cash at end of period
29,648
23,829
24,290
60,445
31,087
-
Free cash flow
Operating cash flow
-27,396
-26,768
-25,526
-24,128
-12,536
-
Capital expenditure
-841
-613
-361
-251
-11
-
Free cash flow
-28,237
-27,381
-25,887
-24,379
-12,547
-